Issue link: https://www.e-digitaleditions.com/i/1138630
32L July 2019 Tablets & Capsules expected to represent 33 percent of the dietary supplement market share by the end of the forecast period as working experts and sports competi- tors find more applications for vitamin ingredients in multivitamin tablets, powders, and fluids. The tablet is the most popular form for dietary supple- ment products because of its long shelf life and ease of manufacturing. The tablet segment is expected to rep- resent 35 percent of the total market nutra news Dietary supplements market to exceed $211 billion by 2026 ROWLAND HEIGHTS, CA— The global dietary supplements mar- ket is forecast to grow at a compound annual rate of 7.9 percent, reaching $211.38 billion by 2026, according to a report by Acumen Research and Consulting. The vitamin segment is share. The report identifies Abbott Laboratories, Amway, Arkopharma Laboratoires Pharmaceutiques, Glan- bia, Bayer, Pfizer, Carlyle Group, Archer Daniels Midland, NBTY, Nu Skin Enterprises, Herbalife Interna- tional, GlaxoSmithKline, Nature's Sunshine Forms, and Bionova Life- sciences as major players in the global dietary supplements market. ODS funds research on dietary supplements BETHESDA, MD—The office of dietary supplements (ODS) will fund research on the role of dietary supple- ments and/or their ingredients on health maintenance and disease pre- vention. ODS has committed $6 mil- lion to fund 20 research awards in 2019 and another 20 research awards in 2020. Primary consideration will be given to areas of dietary supple- ment research that are lacking or lag- ging; that clarify gaps, opportunities, and balance between benefits and risks where data conflicts; that target special population groups where additional science on dietary supple- ments is needed; and that focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease. ODS will also fund validation stud- ies of analytical methods for dietary supplement constituents, building on existing National Institute of Health awards to support the performance and publication of formal single-labo- ratory validation studies of quantita- tive analytical methods. ODS has committed $1 million to fund four awards per fiscal year in 2019 and 2020. The methods proposed for vali- dation must be used to identify and quantify dietary supplement-relevant chemical constituents, such as chemi- cal compounds, adulterants, and con- taminants, or their metabolites in experimental reagents, raw materials, and/or clinical specimens. Applica- tions are due October 15, 2019. FDA publishes ingredient advisory S I L V E R S P R I N G , M D — T h e FDA published the Dietary Supple- ment Ingredient Advisory List, an online reference intended to alert 6982 Bandini Blvd., Los Angeles, CA 90040 | Toll Free: (800) 360-SGTI | Phone: (323) 726-0700 focus@soft-gel.com | www.soft-gel.com %7MRKYPEV*SGYW We make softgels. Various shapes, sizes, and colors. Custom and stock formulas. Solvent-free. That's all we do. In a GMP-certified U.S. facility. We do one thing and we do it well. By choosing us as your softgel contract manufacturer, you can concentrate on what you do best. If we may have your attention for a moment, we'll make you the center of attention. Contact us today. Delivering custom and branded softgels, naturally. ™